The National Institutes of Health (NIH) National Cancer Institute has granted $124,000 to Aastrom Biosciences, Inc. to develop an immunotherapeutic treatment of malignant melanoma using AastromReplicell System cell production technology.
Combination Surgery Plus Adalimumab More Clincially Effective in HS Than Adalimumab Alone
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Pointers With Portela: Treating Fungal Acne
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
POLL: What Strategies Have You Found Most Effective in Managing Alopecia?
Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York
2 Clarke Drive Cranbury, NJ 08512